Biotech and Pharmaceutical
News & Jobs

Search the Site

Employers
Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

News | News By Subject | News by Disease | News By Date | Search News

Breast Cancer News Articles

Get Our Industry eNewsletter FREE

email:

Top Breaking News

Pfizer Inc.'s Palbociclib Gets FDA Breakthrough Label 4/12/2013 More...

Novartis AG Breast Cancer Drug Rejected Despite Being Hailed as a "Breakthrough" 3/25/2013 More...

Navidea Biopharmaceuticals's Lymphoseek Gets FDA Approval 3/15/2013 More...

EU Approves Roche's Perjeta to Treat Metastatic Breast Cancer 3/6/2013 More...

FDA Approves Genentech's Drug for Late-Stage Metastatic Breast Cancer 2/26/2013 More...

Puma Biotechnology Reaches Deal With FDA on SPA for Phase III Trial of PB272 2/20/2013 More...

Pfizer Inc. May Push $5 Billion Breast Cancer Hope for Ruling 1/10/2013 More...

MA Women at Trial: Eli Lilly and Company Pregnancy Drug Caused Our Cancers 1/9/2013 More...

Roche Wins EU Backing for Perjeta Breast Cancer Drug 12/14/2012 More...

Genentech's Perjeta Extends Life of Breast Cancer Patients by 34 Pct 12/11/2012 More...

Pfizer Inc. New Breast Cancer Drug Heralded as Breakthrough 12/10/2012 More...

Cipla Ltd. Slashes Cancer Drug Prices by Up to 64 Pct 11/8/2012 More...

GlaxoSmithKline, Roche Drugs Help Treat Breast Cancer in Brain 11/2/2012 More...

Cancer Trials Show One Year on Roche's Herceptin is Best 10/1/2012 More...

Dueling Tests Pressure Roche Bet on Herceptin 9/24/2012 More...

Featured Stories

A Cautionary Perspective on Angelina Jolie's Double Mastectomy 5/15/2013 More...

University of Texas MD Anderson Cancer Center Study Reveals Magnitude of Variation in Gene Expression Measurements Within Breast Cancers 5/3/2013 More...

Certain Breast Cancers Have a Trait That Could Be Attacked by New Therapies, University of Missouri Study 3/29/2013 More...

Manipulating Transcription Factor Can Change Subtype of Breast Cancer, Garvan Institute of Medical Research Study 1/2/2013 More...

Ability to Metabolize Tamoxifen Affects Breast Cancer Outcomes, Mayo Clinic Study 12/27/2012 More...

Vanderbilt University Medical Center Study Finds Diverse Genetic Alterations in Triple-Negative Breast Cancers 12/10/2012 More...

Periods Clue to Breast Cancer Onset, University of Oxford Study 10/18/2012 More...

New Insights on Control of Pituitary Hormone Outside of Brain Has Implications for Breast Cancer, University of Pennsylvania Study 10/1/2012 More...

National University of Singapore (NUS) Study Links Another Gene Variant to Male Breast Cancer 9/24/2012 More...

Exercise, Even Mild Physical Activity, May Reduce Breast Cancer Risk, University of North Carolina Study 6/25/2012 More...

Dieting May Lower Hormone Levels Tied to Breast Cancer, Fred Hutchinson Cancer Research Center Study 5/22/2012 More...

Soy Supplements May Not Protect Against Breast Cancer, Northwestern University Study 2/6/2012 More...

University of Michigan Researchers Find Genetic Rearrangements Driving 5 to 7 Percent of Breast Cancers 11/22/2011 More...

Drug Prevents Bone Loss Side Effects of Breast Cancer Medication, University of Pittsburgh Cancer Institute (UPCI) Study 10/14/2011 More...

Survival Increases in Early Stage Breast Cancer After Treatment With Herceptin and Chemo, University of California, Los Angeles (UCLA) Study 10/6/2011 More...

More News

AlphaMed Release: Study Shows Dual Targeting of HER2 and HR-Positive Metastatic Breast Cancer Improves Survival Rates 5/7/2013 More...

Oasmia Initiates Clinical Program With Paclical® in Metastatic Breast Cancer 5/6/2013 More...

Bio-Matrix Scientific Group Inc. (BMSN.OB)'s Regen BioPharma Acquires Cancer Vaccine Technology With Initial Focus on Breast Cancer 5/6/2013 More...

Sunshine Biopharma, Inc. Narrows Kilogram Manufacturing Options for Adva-27a Breast Cancer Drug Candidate to Three Suppliers 5/1/2013 More...

GTx, Inc. (GTXI) Initiating Phase 2, Open-Label Study of Enobosarm to Treat ER Positive Metastatic Breast Cancer 4/30/2013 More...

Roche (RHHBY) Release: Health Canada Approves PERJETA™, a New First-In-Class Targeted Therapy for the Treatment of HER2-Positive Metastatic Breast Cancer(1) 4/23/2013 More...

Galapagos NV (GLPG.BR) Discovers Novel Candidate Drug to Treat Breast Cancer 4/22/2013 More...

Eddingpharm (Cayman) Inc. to Distribute Breast Cancer Drug for GlaxoSmithKline (GSK) in China 4/9/2013 More...

Arno Therapeutics Reports Activated Progesterone Receptors Predictive of Response to Onapristone 4/8/2013 More...

Aragon Pharmaceuticals, Inc. Announces First Patient Dosed in Phase I Study of ARN-810 in Estrogen Receptor Positive Breast Cancer 4/4/2013 More...

Navidea Biopharmaceuticals (NAVB) Release: Results of Lymphoseek® Phase 3 Clinical Trials in Breast Cancer Published in Annals of Surgical Oncology 3/21/2013 More...

Sunshine Biopharma, Inc. Commences Negotiations With Contract Manufacturing Organizations for Production of Its Multidrug-Resistant Breast Cancer Drug, Adva-27a 3/14/2013 More...

AlphaMed Release: Therapeutic Combination for HER2-Positive Breast Cancer Does Not Increase Cardiac Problems, but Cancer Patients' Heart Health Should be Monitored 3/8/2013 More...

APEIRON Biologics AG Release: Success in Avoiding Radiation Skin Damage for Breast Cancer Patients 3/5/2013 More...

Sunshine Biopharma, Inc. Reports on IND Research for Its Novel Breast Cancer Drug Candidate, Adva-27a 2/26/2013 More...